Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Dec 14, 2021 10:41pm
241 Views
Post# 34231403

RE:RE:Inv Presentation off website, both FR & EN

RE:RE:Inv Presentation off website, both FR & ENWe should probably make sure our calendars are clear every morning for a few days as that sounds to me that something is going to be announced soon that would require a revamp of the presentation. We already know several things it could be if there is some major announcement but we certainly do not know everything it could be. Hoping for an especially merry Christmas for all!

ANALIAS00 wrote:

It was said before. They should not remove it but they should replace it.



There is no reason to leave the website without this presentation.

I really dont know why they took that bad habit.

If they were ahead of everything I would not be complaining but since the stock is sooo undervalued as per PL, I would pay attention to small and basic details.
Wino115 wrote: Seems they've taken down the Jul 19 investor presentation. Have to assume it's being updated with all the year end data at a minimum and perhaps more --I hope. We'll see if it comes back quickly or takes a while like it did once before. 




<< Previous
Bullboard Posts
Next >>